AIMS LEAP Timepoint 1 (T1) and Timepoint 2 (T2)
ELU-4-4D20BB-1

Export Metadata as DATS

The Longitudinal European Autism Project (LEAP) is currently the largest study in the world to identify variability in autism in terms of behaviour, cognition, co-occurring conditions, outcomes, brain structure/function and genetics. AIMS-LEAP participants have been followed up longitudinally over time, with the current dataset including Timepoint 1 and Timepoint 2 (approx. 12-24-months apart).

Project

Project Title: AIMS Longitudinal European Autism Project
Project website: https://www.aims-2-trials.eu/leap-front-page/

Datasets

Study description

Primary Purpose: Autism Innovative Medicines Studies - Longitudinal European Autism Project (AIMS - LEAP)
Study Types: Clinical trial NCIT C71104
Description of Cohorts: 437 autistic individuals and 300 non-autistic individuals total. Please note that N for individual datasets available here will be lower, and will differ between data modalities, due to participant consent preferences for external sharing and data quality. Total number 734 can vary depending on the study measure and timepoint, as well as participant consent preferences for external data sharing
Informed Consent Given?: True
Multi-center Study?: True